Singapore markets closed
  • Straits Times Index

    -79.29 (-2.54%)
  • S&P 500

    +60.65 (+1.32%)
  • Dow

    +236.60 (+0.68%)
  • Nasdaq

    +291.18 (+1.88%)

    -605.87 (-1.06%)
  • CMC Crypto 200

    +5.75 (+0.40%)
  • FTSE 100

    -92.87 (-1.31%)
  • Gold

    +13.60 (+0.76%)
  • Crude Oil

    -1.88 (-2.69%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Nikkei

    -462.16 (-1.63%)
  • Hang Seng

    -376.98 (-1.58%)
  • FTSE Bursa Malaysia

    +3.41 (+0.23%)
  • Jakarta Composite Index

    -74.36 (-1.13%)
  • PSE Index

    -77.56 (-1.07%)

Global RNA Analysis Market Research Report 2021 -

·4-min read

DUBLIN, October 21, 2021--(BUSINESS WIRE)--The "Global RNA Analysis Market 2021-2026" report has been added to's offering.

This study offers a global view of RNA analysis for various applications. This report analyzes and assesses different types of RNA analysis involved, namely microarrays, polymerase chain reaction (PCR), sequencing technologies, and RNAi gene silencing. It also provides information by application, categorized as clinical diagnosis, drug discovery and toxicogenomics.

RNA analysis can reveal diseases and systems that contribute to death, and this type of analysis can be a useful tool in forensic pathology for determining the cause of death. RNA species (messenger RNA, transfer RNA, and ribosomal RNA) play an important role in the translation of genetic information from DNA to proteins.

MicroRNA and other short, non-coding RNAs have lately been discovered to have new functions in gene regulation. From large-scale analyses of the transcriptome - the whole collection of RNA transcripts encoded by a genome - to exploring the actions of individual short, non-coding RNAs on specific genes, RNA analysis research encompasses a wide range of issues.

For gene expression analysis, RT-qPCR is a must-have tool. During an experiment, RT-qPCR devices are used to detect and monitor the expression of specific RNA targets in real-time.

RNases (RNA-degrading enzymes) are ubiquitous. It is crucial to successfully isolate RNA and keep it intact, especially when delicate downstream applications are involved (e.g., RNA sequencing). All RNA purification and handling should take place in a lab that is RNase-free and RNA-only, and gloves should be used at all times to avoid contamination. Using an RNase inhibitor to protect samples from RNase degradation is crucial.

This report explores the present and future market values of the RNA analysis market, particularly by type of analysis such as microarrays, polymerase chain reaction (PCR), sequencing technologies, and RNAi gene silencing. Market analysis for applications such as clinical diagnosis, drug discovery and toxicogenomics is also explored in the report.

Also included in the report is a discussion of the impact of COVID-19 on the market and profiles of leading companies in the RNA analysis market. The leading firms in the market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories, CD Genomics, Promega Corp., Illumina Inc., Qiagen NV, Danaher Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, Fluidigm Corp., and Eurofins Scientific.

The Report Includes

  • Analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026

  • Detailed analysis of the current market trends and forecast, relevant R&D activities, new products launches and product enhancement in the industry and discussion of regulatory elements that are affecting the future marketplace

  • A detailed description of RNA analysis types such as microarrays, polymerase chain reaction (PCR), sequencing technologies, and RNAi gene silencing, and coverage of their industry structure

  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies

  • Company profiles of major players in the market including Agilent Technologies Inc., Bio-Rad Laboratories Inc., CD Genomics, Danaher, Roche, Illumina Inc., Merck KGAA, Qiagen, Thermo Fisher Scientific Inc.

Key Topics Covered:

Chapter 1 Introduction

  • Scope of the Report

  • Reasons for Doing This Study

  • Information Sources

  • Research Methodology

  • Geographic Breakdown

  • Analyst's Credentials

  • Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview

  • Impact of COVID-19 on the Market for RNA Analysis/Transcriptomics

Chapter 4 Global Market for RNA Analysis/Transcriptomics

  • Global Market for RNA Analysis/Transcriptomics

  • Global Market for RNA Analysis/Transcriptomics by Technology

  • Polymerase Chain Reaction

  • Sequencing Technologies

  • Microarrays

  • RNAi Gene Silencing

  • Global Market for RNA Analysis/Transcriptomics by Application

  • Drug Discovery

  • Toxicogenomics

  • Clinical Diagnosis

  • Global Market for RNA Analysis/Transcriptomics by Region

Chapter 5 Drivers and Challenges

  • Market Drivers

  • Growing Research in Transcriptomics

  • Increasing Research in Medicinal Plant Transcriptomics

  • Market Challenges

  • Working with Huge Volumes of Data

Chapter 6 Supplier Landscape, Company Share Analysis and Company Profiles

  • Mergers and Acquisitions

  • Company Share Analysis

  • Company Profiles

  • Agilent Technologies Inc.

  • Bio-Rad Laboratories Inc.

  • CD Genomics

  • Danaher Corp.

  • Eurofins Scientific

  • F. Hoffmann-La Roche Ltd.

  • Fluidigm Corp.

  • Illumina Inc.

  • Merck Kgaa

  • Promega Corp.

  • Qiagen NV

  • Thermo Fisher Scientific Inc.

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting